These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1371534)

  • 1. Viral culture and p24 antigenemia of human immunodeficiency virus (HIV)-infected individuals correlated with antibody profiles determined with recombinant polypeptides of all HIV-1 open-reading frames.
    Baur A; Vornhagen R; Korn K; Sonneborn HH; Eberlein B; Harrer T; Brockhaus W; Jahn G
    J Infect Dis; 1992 Mar; 165(3):419-26. PubMed ID: 1371534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earlier detection of human immunodeficiency virus type 1 p24 antigen and immunoglobulin G and M antibodies to p17 antigen in seroconversion serum panels by immune complex transfer enzyme immunoassays.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Ishikawa E
    Clin Diagn Lab Immunol; 2000 Nov; 7(6):872-81. PubMed ID: 11063490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominant epitopes of HIV-1 p17 and p24.
    Graham S; Follett EA; Wallace L; Desselberger U; Marsden HS
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1781-8. PubMed ID: 1280955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of human immunodeficiency virus type 1 antibody reactivity by western immunoblots: evaluation of relative antibody levels in seropositive individuals and mothers.
    Geffin RB; Lai SH; Hutto C; Scott GB; Scott WA; Master M; Parks WP
    J Infect Dis; 1992 Jan; 165(1):111-8. PubMed ID: 1727880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors.
    Sayre KR; Dodd RY; Tegtmeier G; Layug L; Alexander SS; Busch MP
    Transfusion; 1996 Jan; 36(1):45-52. PubMed ID: 8607152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal conditions of immune complex transfer enzyme immunoassays for antibody IgGs to HIV-1 using recombinant p17, p24, and reverse transcriptase as antigens.
    Hashida S; Ishikawa S; Hashinaka K; Nishikata I; Oka S; Shimada K; Saito A; Takamizawa A; Shinagawa H; Ishikawa E
    J Clin Lab Anal; 1998; 12(2):98-107. PubMed ID: 9524294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
    Madaule P; Gairin JE; Bénichou S; Rossier J
    FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in human immunodeficiency virus type 1 (HIV-1) anti-p24 reactivities in serum of HIV-1-infected and uninfected subjects: analysis of indeterminate western blot reactions.
    Povolotsky J; Gold JW; Chein N; Baron P; Armstrong D
    J Infect Dis; 1991 Feb; 163(2):247-51. PubMed ID: 1899100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of viral-lysate enzyme-linked immunosorbent assay kits for detecting human immunodeficiency virus (type 1) infections using human sera standardized by quantitative western blotting.
    Hardy CT; Damrow TA; Villareal DB; Kenny GE
    J Virol Methods; 1992 Jun; 37(3):259-73. PubMed ID: 1378850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression.
    Chargelegue D; Stanley CM; O'Toole CM; Colvin BT; Steward MW
    Clin Exp Immunol; 1995 Feb; 99(2):175-81. PubMed ID: 7851008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliable confirmation and quantitation of human immunodeficiency virus type 1 antibody using a recombinant-antigen immunoblot assay.
    Busch MP; el Amad Z; McHugh TM; Chien D; Polito AJ
    Transfusion; 1991 Feb; 31(2):129-37. PubMed ID: 1899951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of the IgG antibody response to HIV-1 p17 gag protein in HIV-1+ patients with haemophilia: titre and avidity.
    Chargelegue D; O'Toole CM; Colvin BT
    Clin Exp Immunol; 1993 Sep; 93(3):331-6. PubMed ID: 8370162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.